Rare diseases
Investigational molecules
Locations
Study of oral BI 1815368 compared to placebo in patients with diabetic macular edema over 48 weeks of treatment
GermanyStudy of typology-based coaching and education to help patients with early hormone-positive HER2-negative breast cancer manage their treatment with ribociclib
GermanyStudy of ivosidenib maintenance treatment in patients with IDH1-mutated cholangiocarcinoma after standard chemotherapy
GermanyStudy of momelotinib tablets in patients with anemia caused by low-risk myelodysplastic syndrome
GermanyStudy of Nucresiran in Adults with Transthyretin Amyloidosis with Cardiomyopathy to Evaluate its Effects on Survival and Heart Problems
GermanyLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
GermanyStudy of ficerafusp alfa and pembrolizumab as first treatment for patients with PD-L1-positive recurrent or metastatic head and neck cancer
GermanyStudy of felzartamab compared to placebo in adults with IgA nephropathy
GermanyStudy of GHZ339 for treatment of moderate to severe atopic dermatitis
GermanyStudy of drug combination therapy for prevention of recurrent stroke in patients with acute ischemic stroke and atrial fibrillation
GermanyStudy of zoldonrasib with daraxonrasib, pembrolizumab and chemotherapy in patients with RAS G12D-mutant non-small cell lung cancer
GermanyStudy of intestinal gel containing levodopa, carbidopa and entacapone to treat motor and behavioral symptoms in patients with Parkinson's disease
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
